✦ LIBER ✦

Changing the gold standard in adjuvant therapy for breast cancer: from tamoxifen to aromatase inhibition

✍ Scribed by S. Glück

Book ID: 117575723
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 196 KB
Volume: 59
Category: Article
ISSN: 0753-3322
DOI: 10.1016/s0753-3322(05)80062-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switching from tamoxifen to aromatase in

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer

✍ C.J.H. van de Velde; S. Verma; J.G.H. van Nes; C. Masterman; K.I. Pritchard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Switching from tamoxifen (TAM) to aromat

Switching from tamoxifen (TAM) to aromatase inhibitors (Als) in the adjuvant treatment of breast cancer (BC) patients (pts). Results from the NORA study

✍ M.E. Cazzaniga; Mustacchi; P. Pronzato; A. De Matteis; F. Di Costanzo; E. Rulli; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Stick or switch? Audit of the use of swi

Stick or switch? Audit of the use of switch therapy from tamoxifen to an aromatase inhibitor in breast cancer

✍ S Weeraman, C Hunsley, M Wall, R Kirby 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 390 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

Pilot study of acupuncture for the treat

Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients

✍ Katherine D. Crew; Jillian L. Capodice; Heather Greenlee; Arlyn Apollo; Judith S 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

PCN119 COST EFFECTIVENESS ANALYSIS OF AN

PCN119 COST EFFECTIVENESS ANALYSIS OF ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT THERAPY FOR EARLY STAGE BREAST CANCER BASED ON THE 100-MONTH ANALYSIS OF THE ATAC TRIAL FROM A GERMAN PERSPECTIVE

✍ N Kreif; Á Benedict; MP Lux; A Wöckel; MB Klevesath 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB